Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir
Journal of Clinical Investigation · 16.01.2025 · 135 (2)
DOI: 10.1172/jci183952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 29.11.2024. Verfasst von Irene González-Navarro und 18 weiteren Autor:innen. Beteiligte Einrichtung: IrsiCaixa, Badalona, Barcelona, Spain. Hauptthemen laut MEDLINE: Anti-Retroviral Agents, HIV Infections, HIV-1. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH/NIAID, Merck Sharp & Dohme.
Abstract (Originalsprache)
BACKGROUND Antiretroviral therapy (ART) has improved the clinical management of HIV-1 infection. However, little is known about how the latest ART recommendations affect the heterogeneity of the HIV-1 reservoir size. METHODS We used a complete statistical approach to outline parameters underlying the diversity in HIV-1 reservoir size in a cohort of 892 people with HIV-1 (PWH) on suppressive ART for more than 3 years. Total HIV-1–DNA levels were measured in PBMCs using digital droplet PCR (ddPCR). RESULTS We classified 179 (20%) participants as being low viral reservoir treated (LoViReT) (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IrsiCaixa, Badalona, Barcelona, Spain.
- Department of Cellular Biology, Physiology and Immunology, Faculty of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
- Biomedical Research Networking Center on Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), Madrid, Spain.
- Germans Trias i Pujol Research Institute (IGTP), Campus Can Ruti, Badalona, Spain.
- Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Germans Trias i Pujol University Hospital (HUGTiP), Badalona, Spain.
- Chair in Infectious Diseases and Immunity, University of Vic - Central University of Catalonia (UVic-UCC), Vic, Spain.
Förderung
- NIAID NIH HHS
- NIH/NIAID
- Merck Sharp & Dohme
Zitieren
APA
González-Navarro, I., Urrea, V., Gálvez, C., Garcia-Guerrero, M. D. C., Morón-López, S., Puertas, M. C., Grau, E., Mothe, B., Bailón, L., Miranda, C., García, F., Leal, L., Vandekerckhove, L., Marconi, V. C., Sekaly, R. P., Clotet, B., Martinez-Picado, J., Salgado, M., & NIH Reversing Immune Dysfunction for HIV-1 Eradication (RID-HIV) Collaboratory Group (2025). Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir. Journal of Clinical Investigation, 135(2). https://doi.org/10.1172/jci183952
Vancouver
González-Navarro I, Urrea V, Gálvez C, Garcia-Guerrero MDC, Morón-López S, Puertas MC, et al. Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir. Journal of Clinical Investigation. 2025;135(2). doi:10.1172/jci183952
BibTeX
@article{GonzlezNavarro2025,
author = {González-Navarro, Irene and Urrea, Víctor and Gálvez, Cristina and Garcia-Guerrero, Maria Del Carmen and Morón-López, Sara and Puertas, Maria C and Grau, Eulàlia and Mothe, Beatriz and Bailón, Lucía and Miranda, Cristina and García, Felipe and Leal, Lorna and Vandekerckhove, Linos and Marconi, Vincent C and Sekaly, Rafick P and Clotet, Bonaventura and Martinez-Picado, Javier and Salgado, Maria and NIH Reversing Immune Dysfunction for HIV-1 Eradication (RID-HIV) Collaboratory Group, NIH Reversing Immune Dysfunction for HIV-1 Eradication (RID-HIV) Collaboratory Group},
title = {Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {2},
doi = {10.1172/jci183952}
}
EUVIMED